Advertisement
  • Survivor Profile

    A Long Road Back

    Multiple myeloma survivor Gary Lambert deploys inventiveness and fortitude to deal with cancer.

    by Lindsey Konkel

  • Advocacy Spotlight: Sorting Out Priorities

    Ovarian cancer survivor and research advocate Annie Ellis is teaming up with researchers to better equip patients with recurrent cancer to make treatment decisions.

    by Cici Zhang

  • Bill Aims to Improve Childhood Cancer Research

    The STAR Act passes in the U.S. House of Representatives.

    by Brad Jones

  • Healing Through Art

    The Breast Cancer Art Project encourages breast cancer patients and survivors to produce—and share—art about their cancer experiences.

    by Ashley P. Taylor

  • Brain Cancer Patients Make Connections

    An app developed for glioblastoma patients allows them to track their symptoms and contribute to research.

    by Brad Jones

  • Non–Small Cell Lung Cancer Takes Center Stage

    A trio of clinical trials at the AACR Annual Meeting spotlight new avenues for non-small cell lung cancer treatment.

    by Brad Jones

  • Pembrolizumab Shows Further Promise for Melanoma

    In a phase III clinical trial, pembrolizumab yielded a 75.4 percent recurrence-free survival rate after 12 months among patients whose stage III melanoma tumors had been fully resected.

    by Brad Jones

  • Making Decisions About Breast Surgery

    Patients who opt for breast reconstruction after mastectomy tend to overestimate how happy they will be with the results, while those who do not get reconstruction tend to underestimate their future satisfaction.

    by Cici Zhang

  • A Better Way to Screen for Lynch Syndrome?

    Researchers say a next-generation sequencing test could improve screening in colorectal cancer patients for a hereditary syndrome that raises cancer risk. Some experts have concerns.

    by Cheryl Platzman Weinstock

  • Q&A

    Keeping Options Open

    Research scientist Teresa Woodruff is determined to make fertility preservation accessible to more young adults and children with cancer.

    by Delia O'Hara